{"disease":{"id":"hyperlipidemia-dyslipidemia","name":"hyperlipidemia dyslipidemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02991534","title":"Cardiovascular Risk Screening and Risk Reduction in Women Vets","phase":"NA","overall_status":"COMPLETED","enrollment_count":6009,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT01854918","title":"Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3681,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT06694012","title":"Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Osaka Metropolitan University","has_results":false},{"nct_id":"NCT02662569","title":"Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":986,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT07253584","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of SAL003 in Combination With Statin Therapy in Patients With Hypercholesterolemia and Mixed Dyslipidemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":720,"lead_sponsor_name":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT02833844","title":"Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":467,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT02729025","title":"Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT03718286","title":"Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"Population Health Research Institute","has_results":false},{"nct_id":"NCT02189837","title":"Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT04606602","title":"Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Silence Therapeutics plc","has_results":false},{"nct_id":"NCT03961763","title":"Effect of n-3 Fatty Acid Supplementation in Hyperlipidemic Patients Taking Statins","phase":"NA","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"University of Chester","has_results":false},{"nct_id":"NCT02275156","title":"Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT04094194","title":"Meta-analysis of the Nordic Dietary Pattern on Cardiometabolic Risk and Cardiovascular Outcomes","phase":"","overall_status":"UNKNOWN","enrollment_count":1,"lead_sponsor_name":"University of Toronto","has_results":false},{"nct_id":"NCT02947334","title":"Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Pfizer","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}